Raymond James Trust N.A. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 2.5% during the second quarter, HoldingsChannel reports. The fund owned 4,758 shares of the medical equipment provider's stock after acquiring an additional 115 shares during the quarter. Raymond James Trust N.A.'s holdings in Intuitive Surgical were worth $955,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 28,519,307 shares of the medical equipment provider's stock valued at $8,603,704,000 after buying an additional 457,262 shares during the period. BlackRock Inc. lifted its position in shares of Intuitive Surgical by 0.5% in the 1st quarter. BlackRock Inc. now owns 26,660,811 shares of the medical equipment provider's stock worth $8,043,033,000 after acquiring an additional 122,151 shares during the period. State Street Corp grew its holdings in shares of Intuitive Surgical by 2.3% during the 1st quarter. State Street Corp now owns 15,182,214 shares of the medical equipment provider's stock worth $4,580,170,000 after purchasing an additional 347,468 shares in the last quarter. Capital World Investors increased its position in shares of Intuitive Surgical by 0.3% during the first quarter. Capital World Investors now owns 9,687,380 shares of the medical equipment provider's stock valued at $2,922,569,000 after purchasing an additional 28,839 shares during the period. Finally, Edgewood Management LLC raised its stake in shares of Intuitive Surgical by 20.3% in the first quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider's stock valued at $2,685,761,000 after purchasing an additional 1,504,353 shares in the last quarter. 82.44% of the stock is currently owned by institutional investors and hedge funds.
Get Intuitive Surgical alerts:Wall Street Analyst Weigh In
ISRG has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Intuitive Surgical from $225.00 to $205.00 in a research note on Friday, July 22nd. Piper Sandler upped their target price on shares of Intuitive Surgical from $255.00 to $260.00 and gave the company an "overweight" rating in a research note on Thursday, August 18th. Evercore ISI cut their price target on shares of Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. The Goldman Sachs Group lowered their price objective on Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a research note on Friday, July 29th. Finally, BTIG Research cut their target price on Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating for the company in a research report on Monday, July 18th. Six research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $268.00.
Intuitive Surgical Trading Down 0.3 %
Shares of ISRG stock opened at $190.52 on Friday. The firm has a market capitalization of $68.04 billion, a price-to-earnings ratio of 48.48, a PEG ratio of 5.45 and a beta of 1.31. The firm's 50 day moving average is $218.90 and its 200-day moving average is $232.86. Intuitive Surgical, Inc. has a 1 year low of $186.83 and a 1 year high of $369.69.Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.04 by ($0.19). The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same period in the prior year, the company posted $1.42 EPS. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current fiscal year.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the company's stock in a transaction dated Thursday, September 8th. The shares were sold at an average price of $210.76, for a total transaction of $1,343,595.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,365,570.24. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Intuitive Surgical news, CEO Gary S. Guthart sold 79,412 shares of Intuitive Surgical stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the sale, the chief executive officer now owns 54,607 shares of the company's stock, valued at approximately $11,811,494.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $210.76, for a total value of $1,343,595.00. Following the completion of the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,365,570.24. The disclosure for this sale can be found here. Insiders have sold a total of 101,162 shares of company stock worth $22,062,916 over the last 90 days. Insiders own 0.90% of the company's stock.
About Intuitive Surgical
(Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.